1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Chronic Subdural Hematoma: new trials by email Literature Review of Chronic Subdural Hematoma trials Research Report on Chronic Subdural Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD) Memantine Hydrochloride, Placebo - Chronic Subdural Hematoma | Early Phase 1 | Withdrawn | University of New Mexico | 2022-06-01 | 2026-02-27 |
Hematoma, Subdural, Chronic (1)
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Chronic Disease (1) · Craniocerebral Trauma (1) · Disease Attributes (1) · Hematoma (1) · Hematoma, Subdural (1) · Hemorrhage (1) · Intracranial Hemorrhage, Traumatic (1) · Intracranial Hemorrhages (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Memantine (1)
United States (1)